Prosecution Insights
Last updated: October 14, 2026

Hamilton, Brook, Smith & Reynolds, P.C.

Technology area: Biotechnology & Pharmaceuticals

177 pending office actions • 100 clients • 174 examiners • 132 art units • 0 of 177 (0%) have an AI response strategy ready

Analysis

HAMILTON, BROOK, SMITH & REYNOLDS, P.C. manages 12553 career applications, primarily in Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate_pct of 77.6. Prosecution requires an avg_office_actions_per_allowance of 3.85, suggesting a persistent prosecution style necessary for complex biotech patents.

The firm currently has 146 pending office actions. With a large portfolio of 12553 career applications, the 77.6 allowance rate is a significant indicator of their performance in the life sciences. The 3.85 office actions per allowance reflects the iterative nature of examination in the Biotechnology & Pharmaceuticals sector. For practitioners, these metrics highlight a firm with extensive experience and a consistent ability to navigate the challenges of biotech patent prosecution over a very large number of cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=12555 apps, methodology: how we score firms)

77.6%
Allowance Rate
n=12555
+0.54σ
Allowance Rate (norm)
n=12555
3.8
OAs to Allowance
n=6221
+0.17σ
OAs to Allow (norm)
n=6221
1182 days
Time to Allowance
n=6221
+14.6pp
Interview Lift
n=12555
31.2%
RCE Rate
n=12555
1.4%
Appeal Rate
n=12555

Rejection Performance (% of received rejections ultimately overcome)

81.8%
§101 Overcome
n=1250
78.4%
§102 Overcome
n=2617
79.2%
§103 Overcome
n=4250
80.2%
§112 Overcome
n=2938

Specialization & Scale

A61K, G06F, A61P
Top CPC Subclasses
19%
Top-3 CPC Share
n=12555
28
Practitioners
n=12555
448.4
Apps / Practitioner
n=12555

Portfolio Summary

177
Total Pending OAs
103
Non-Final OAs
66
Final Rejections
8
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 55 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

31
Overdue
3
Due this week
11
Due this month
8
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 55 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (31)Due ≤ 7 days (3)Due ≤ 30 days (11)Due ≤ 60 days (8)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

89
Hard (50%)
76
Medium (43%)
9
Easy (5%)
3
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only6 (3%)
§101 + other20 (11%)
§103 only57 (32%)
§102 only10 (6%)
§112 only8 (5%)
Double-patenting only1 (1%)
Double-patenting + other9 (5%)
Multi-statute (no §101)63 (36%)
No statute on record3 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

88
Life Sciences
50% of docket
32
Information Tech
18% of docket
8
Communications
5% of docket
15
Semiconductors
8% of docket
32
Mechanical / Eng
18% of docket
2
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,770 h
Manual time on pending OAs
354 h
Time saved (low, 20%)
620 h
Time saved (mid, 35%)
15.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SANG, HONG 3 55.0% +62.6%
WOZNICKI, JACQUELINE 2 49.8% +26.1%
HRANEK, KAREN AMANDA 1 34.4% +39.9%
TOLEDO-DURAN, EDWIN J 1 70.2% +32.0%
BECK, LERON 1 80.3% +10.8%
JEAN GILLES, JUDE 1 92.8% +2.5%
HOLLOMAN, NANNETTE 1 60.7% +23.2%
HOSSAIN, KAMAL M 1 81.4% +26.6%
WOOD, KIMBERLY T 1 54.8% +27.6%
VASISTH, VISHAL V 1 72.5% +33.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19182761 Automatic Discovery and Reporting of Streaming Content of Interest and Connection of User to Same JEAN GILLES, JUDE —
19073801 Scalable Offloading of Computer Vision Processing Tasks HOSSAIN, KAMAL M —

Hard Cases (89)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17730897 Performing A Deformation-Based Physics Simulation HAO, YI 190d overdue
18328682 ADJUNCTIVE THERAPY FOR DEPRESSION CHONG, YONG SOO 121d overdue
17758847 Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof ANDERSON, REBECCA L 107d overdue
17780961 BIOMASS-BASED SOLID COMPOSITE ELECTROLYTES FOR BATTERIES NGUYEN, KEVIN NMN 56d overdue
18753908 Method And Apparatus For Wireless Communications ARMSTRONG, JONATHAN D 36d overdue
17594150 System and Method for Improving a Processing System using Learning Systems KNIGHT, PAUL M 24d overdue
18608851 Sensor, System and Method for Detecting or Sensing Moisture or Wetness of an Article FERDOUS, ZANNATUL 19d overdue
17820662 SOLID-STATE ELECTROLYTE, CATHODE ELECTRODE, AND METHODS OF MAKING SAME FOR SULFIDE-BASED ALL-SOLID-STATE-BATTERIES VAN KIRK, DUSTIN KENWOOD 18d overdue

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18175345 Methods of Treating High Risk Multiple Myeloma SANG, HONG 10d overdue
16797301 Methods of Treating Newly Diagnosed Multiple Myeloma with a Combination of An Antibody that Specifically Binds CD38, Lenalidomide and Dexamethasone SANG, HONG 4d overdue
19418900 METHODS OF TREATING HIGH RISK MULTIPLE MYELOMA SANG, HONG —
19331792 Methods And Systems For Assessing Cumulative Ergonomic Risk HRANEK, KAREN AMANDA —
19281549 Dam with Contaminants Entombing Cap TOLEDO-DURAN, EDWIN J —
19126030 CALIBRATION OF A CAMERA COORDINATE SYSTEM BECK, LERON —
19088128 Pharmaceutical Formulation HOLLOMAN, NANNETTE —
19073801 Scalable Offloading of Computer Vision Processing Tasks HOSSAIN, KAMAL M —

Client Portfolio (100 clients)

View all 100 →

Top Art Units

Art UnitApps
16464
37743
16253
37913
16533
16323
16543
36842
36782
24442

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19418900 METHODS OF TREATING HIGH RISK MULTIPLE MYELOMA Janssen Biotech, Inc. SANG, HONG 1646 §102§103§112 Final Rejection — Pending Dec 12, 2025
19331792 Methods And Systems For Assessing Cumulative Ergonomic Risk Dassault Systems Americas Corp. HRANEK, KAREN AMANDA 3684 §101§103 Non-Final OA — Pending Sep 17, 2025
19281549 Dam with Contaminants Entombing Cap W.L. French Hydropower Holdings LLC TOLEDO-DURAN, EDWIN J 3678 §102§103§112 Final Rejection — Pending Jul 25, 2025
19126030 CALIBRATION OF A CAMERA COORDINATE SYSTEM Smart Eye AB BECK, LERON 2487 §103§112 Non-Final OA — Pending Apr 30, 2025
19182761 Automatic Discovery and Reporting of Streaming Content of Interest and Connection of User to Same Openexchange, Inc. JEAN GILLES, JUDE 2459 §112DP Non-Final OA — Pending Apr 18, 2025
19088128 Pharmaceutical Formulation Klaria Pharma Holding AB HOLLOMAN, NANNETTE 1612 §102§103§112DP Non-Final OA — Pending Mar 24, 2025
19073801 Scalable Offloading of Computer Vision Processing Tasks Politecnico Di Torino HOSSAIN, KAMAL M 2444 §102 Non-Final OA — Pending Mar 07, 2025
19073852 Cupholder and Phone Mounting System for a Golf Bag Gramse Engineering LLC WOOD, KIMBERLY T 3631 §103 Non-Final OA — Pending Mar 07, 2025
19108603 MWW-STRUCTURED MOLECULAR SIEVE, PREPARATION METHOD THEREFOR AND USE THEREOF Petrochina Company Limited VASISTH, VISHAL V 1771 §103§112DP Non-Final OA — Pending Mar 04, 2025
19106975 IMAGE PROCESSING DEVICE AND METHOD USING ARTIFICIAL NEURAL NETWORK MODEL Korea Advanced Institute Of Science And Technology MAUPIN, HUGH H 2884 §102 Non-Final OA — Pending Feb 26, 2025
19061060 Systems and Methods for Determining Properties of a Wellbore DASSAULT SYSTEMES N'DURE, AMIE MERCEDES 3645 §103 Non-Final OA — Pending Feb 24, 2025
19043414 MODULAR HYDROPOWER SYSTEMS AND METHODS WITH PUMPED STORAGE W.L. French Hydropower Holdings LLC NGUYEN, VIET P 2834 §103 Final Rejection 87d overdue Pending Feb 01, 2025
19016629 Series Enabled Multi-Material Extrusion Technology Mosaic Manufacturing Ltd. KIM, YUNJU 1742 §102§103 Final Rejection — Pending Jan 10, 2025
18986503 RNA Synthesis-Phosphoramidites for Synthetic RNA in the Reverse Direction, and Application in Convenient Introduction of Ligands, Chromophores and Modifications of Synthetic RNA at the 3'-End Chemgenes Corporation DIAMOND, ALAN D 3991 §112Other Non-Final OA — Pending Dec 18, 2024
18983952 Medication Adherence Device And Coordinated Care Platform Watchrx, Inc. BLANCHETTE, JOSHUA B 3684 §101§103 Non-Final OA 40d Pending Dec 17, 2024
18961377 MODULAR PRECAST PUMPED STORAGE HYDRO SYSTEM FOR POWER GENERATION W.L. French Hydropower Holdings LLC FIORELLO, BENJAMIN F 3678 §102§103 Non-Final OA — Pending Nov 26, 2024
18869143 Systems and Methods for Endoluminal Tracking with Therapeutic Delivery Sensing Frond Medical Inc. KIM, KAITLYN EUNJI 3797 §102§103 Non-Final OA — Pending Nov 25, 2024
18869129 METHODS AND SYSTEMS FOR IMAGING INTERACTIONS BETWEEN PARTICLES AND FRAGMENTS UNIVERSITY OF MASSACHUSETTS NAH, JONGBONG 2674 §103 Non-Final OA — Pending Nov 25, 2024
18933478 System and Method for Manipulating Deformable Objects Northeastern University OH, HARRY Y 3657 §103§112 Final Rejection 22d Pending Oct 31, 2024
18932157 Generating, interpreting and adapting a 3D learning environment using ANNs Labster Aps SAINT-VIL, EDDY 3715 §101§103 Non-Final OA — Pending Oct 30, 2024
18923237 SYSTEMS AND METHODS FOR NETWORK CONTROL Granite Telecommunications, LLC ALRIYASHI, ABDULKADER MOHAMED 2447 §103Other Non-Final OA 37d overdue Pending Oct 22, 2024
18856983 PROCESS AND DEVICE FOR ASSEMBLY OF VAN DER WAALS HETEROSTRUCTURES The University of Manchester SWIER, WAYNE K. 1748 §102§103 Non-Final OA — Pending Oct 15, 2024
18909800 Excitation source system and first device for managing backscatter interference Koninklijke Kpn N.V. KUNTZ, CURTIS A 2646 §103§112 Non-Final OA — Pending Oct 08, 2024
18908040 METHOD AND SYSTEM FOR PERCEIVING TRAFFIC ROAD ENVIRONMENT BASED ON GRAPH REPRESENTATION FOR AUTONOMOUS DRIVING Korea Advanced Institute Of Science And Technology PARK, EDWARD 2675 §102§103 Non-Final OA — Pending Oct 07, 2024
18905753 DELIVERY SYSTEM FOR PLACEMENT OF ENDOLUMINAL DEVICES Frond Medical Inc. COCHRAN, KARI LEE 3774 §102§103 Non-Final OA — Pending Oct 03, 2024
18851207 Wearable Holding Device for Neural Implant Headpiece Wyss Center For Bio And Neuro Engineering CIRULNICK, EMILY NICOLE 3792 §103 Final Rejection — Pending Sep 26, 2024
18898619 System And Method For Joint Dynamic Forwarding And Caching In Content Distribution Networks California Institute Of Technology DOAN, HIEN VAN 2449 §103 Final Rejection — Pending Sep 26, 2024
18844869 Vehicular Edge Intelligence in Unlicensed Spectrum Bands Politecnico Di Torino AFRIN, NAZIA 3666 §103 Non-Final OA — Pending Sep 06, 2024
18842756 Fast Well Plate Differential Scanning Micro-Calorimeter Using Photonic Sensors The Charles Stark Draper Laboratory, Inc. LIN, ERICA S Y 2853 §102§103 Non-Final OA — Pending Aug 29, 2024
18841813 Expeditionary Shelter Systems Northeastern University HIJAZ, OMAR F 3635 §103 Non-Final OA — Pending Aug 27, 2024
18837581 Method and Apparatus for Mineral Extraction The University of Manchester MENON, KRISHNAN S 1771 §102§103§112 Non-Final OA — Pending Aug 09, 2024
18782621 CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer Sumitomo Pharma Co., Ltd. ROZOF, TIMOTHY R 1625 §102DP Non-Final OA — Pending Jul 24, 2024
18778572 Distributed System with Fault Tolerance and Self-Maintenance Hyannis Port Research, Inc. BEYEN, ZEWDU A 2461 §103 Non-Final OA — Pending Jul 19, 2024
18773960 Droplet Assembly Method Oxford University Innovation Limited KASS, BENJAMIN JOSEPH 1798 §103§112 Non-Final OA — Pending Jul 16, 2024
18772083 Two stage plating for reduced Ni and NiO layer formation Menlo Microsystems, Inc. DUMBRIS, SETH M 1787 §102§103 Final Rejection — Pending Jul 12, 2024
18771839 Combination Therapies with Anti-CD38 Antibodies Janssen Biotech, Inc. ALSOMAIRY, SARAH ABDOALATIF 1646 §103DP Non-Final OA — Pending Jul 12, 2024
18770438 Smart Eyewear Vision Correction and Adjustment Method and System Plenoptika, Inc. STANFORD, CHRISTOPHER J 2872 §102§103§112 Final Rejection — Pending Jul 11, 2024
18758924 Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy Rutgers, The State University Of New Jersey COUGHLIN, MATTHEW P 1626 §103Other Final Rejection 13d Pending Jun 28, 2024
18759313 ENGINEERED ACID ALPHA-GLUCOSIDASE VARIANTS Crosswalk Therapeutics, Inc. CHOWDHURY, IQBAL HOSSAIN 1656 §102§112 Non-Final OA — Pending Jun 28, 2024
18724306 ZERO DWELL TIME PROCESS MONITORING Virsec Systems, Inc. SHAUGHNESSY, AIDAN EDWARD 2432 §102 Non-Final OA — Pending Jun 26, 2024
18753908 Method And Apparatus For Wireless Communications Northeastern University ARMSTRONG, JONATHAN D 3645 §102§103 Final Rejection 36d overdue Pending Jun 25, 2024
18720067 Zero Trust File Integrity Protection Virsec Systems, Inc. KANAAN, SIMON P 2407 §102 Final Rejection — Pending Jun 14, 2024
18719359 Memory Hybrid-Dynamic Vulnerability Assessment Virsec Systems, Inc. MUNGUIA, DUILIO 2497 §103 Final Rejection 100d overdue Pending Jun 13, 2024
18738572 SYSTEMS AND METHODS FOR STORING A DATAFILE Dassault Systèmes Americas Corp. VUONG, CAO DANG 2153 §102§103 Non-Final OA — Pending Jun 10, 2024
18717878 SALT OF 3,4-DIHYDROISOQUINOLINE COMPOUND AND USE THEREOF Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang) Co., Ltd. VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103DP Non-Final OA — Pending Jun 07, 2024
18715474 JOINT USE OF MULTIPLE WIRELESS RECEIVERS TO SUPPORT MORE DEMANDING DOWNLINK QUALITY-OF-SERVICE REQUIREMENTS Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno RAHMAN, SHAH M 2413 §102§103 Final Rejection — Pending May 31, 2024
18714985 ESTABLISHING LOCAL CONNECTIVITY BETWEEN DEVICES AND APPLICATIONS IN PRIVATE CLOUD ENVIRONMENT Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno CHANG, JUNGWON 2472 §112 Non-Final OA — Pending May 30, 2024
18714827 SYSTEM AND METHOD FOR TELEMETRY DATA BASED EVENT OCCURRENCE ANALYSIS WITH ADAPTIVE RULE FILTER Virsec Systems, Inc. CHRISTENSEN, SCOTT B 2444 §103§112 Final Rejection — Pending May 30, 2024
18714839 USE OF BIFIDOBACTERIUM LACTIS BL-99 IN PREVENTION AND/OR AMELIORATION OF GASTRITIS Inner Mongolia Dairy Tech Res Institute Co. Ltd. CRUM, MARY ABOU NADER 1651 §103§112DP Final Rejection 16d overdue Pending May 30, 2024
18711862 A SOLAR CELL MODULE AND A SOLAR CELL PANEL Epishine AB TRAN, UYEN M 1726 §103 Non-Final OA — Pending May 20, 2024

View all 177 →

Managing Hamilton, Brook, Smith & Reynolds, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Hamilton, Brook, Smith & Reynolds, P.C.'s patent allowance rate?

77.6% of resolved applications prosecuted by Hamilton, Brook, Smith & Reynolds, P.C. were allowed, across 12,555 applications in USPTO records.

How many office actions does Hamilton, Brook, Smith & Reynolds, P.C. average before allowance?

3.85 office actions per allowed application on average.

How many pending office actions does Hamilton, Brook, Smith & Reynolds, P.C. have?

177 pending office actions as of October 2026, for 100 clients, before 174 examiners in 132 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month